List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 225 studies with search of: Open Studies | "Carcinoma, Hepatocellular"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
2 Recruiting A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
3 Not yet recruiting Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: epirubicin;   Drug: Cisplatin
4 Recruiting Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Transarterial Chemoembolization;   Radiation: Proton Beam Radiotherapy
5 Recruiting Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
Conditions: Hepatitis B;   Carcinoma, Hepatocellular;   Polymorphism, Genetic
Intervention:
6 Recruiting Trial for Hepatocellular Carcinoma Related Viral Hepatitis Adjuvant Treatment
Conditions: Carcinoma, Hepatocellular;   Hepatitis, Viral, Human
Intervention: Drug: 131 I-lipiodol
7 Recruiting SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatoma
Intervention: Device: SIR-Spheres microspheres
8 Recruiting Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
9 Recruiting Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
Conditions: Carcinoma, Hepatocellular;   Alcoholic Cirrhosis;   Viral Cirrhosis;   Postoperative Hepatic Failure
Intervention:
10 Recruiting Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Thalidomide(Thado)
11 Recruiting Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib and Gemcitabine
12 Recruiting Dose Escalation Study for Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: Stereotactic Body Radiation
13 Recruiting Dose Escalation Study Using Respiratory Gated Proton Beam Radiotherapy for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: respiratory gated proton beam radiotherapy
14 Recruiting PII Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: TACE;   Procedure: SBRT
15 Recruiting Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas
Condition: Carcinoma, Hepatocellular
Intervention: Drug: idarubicin
16 Recruiting Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: BAY73-4506
17 Recruiting Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Sorafenib (Nexavar, BAY43-9006) + Erlotinib, Tarceva
18 Recruiting Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: BIBF 1120;   Drug: Sorafenib
19 Recruiting BIBF 1120 in Hepatocellular Carcinoma Patients
Condition: Carcinoma, Hepatocellular
Interventions: Drug: BIBF 1120;   Drug: sorafenib
20 Recruiting Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006);   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services